Group 1 - The core viewpoint of the news is that 威高血净's stock has experienced fluctuations, with a current price of 40.58 yuan per share and a market capitalization of 16.694 billion yuan [1] - As of September 9, 威高血净's stock has declined by 2.00% year-to-date, with a 4.88% drop over the last five trading days and a 0.95% decline over the last 20 days, while it has increased by 8.56% over the last 60 days [1] - The company has appeared on the龙虎榜 three times this year, with the most recent appearance on September 3, where it recorded a net buy of -18.4591 million yuan [1] Group 2 - 威高血净 operates in the medical and biological industry, specifically in the medical device and medical consumables sectors [2] - For the first half of 2025, 威高血净 reported a revenue of 1.765 billion yuan, representing a year-on-year growth of 8.52%, and a net profit attributable to shareholders of 220 million yuan, which is a 10.11% increase compared to the previous year [2] - The company has a shareholder base of 31,400 as of June 30, with a decrease of 47.45% from the previous period, while the average number of circulating shares per person has increased by 90.29% [2]
威高血净跌2.00%，成交额8724.14万元，主力资金净流出364.30万元